NEW YORK (GenomeWeb) — Through a non-targeted metabolomics study, Swedish researchers and their colleagues uncovered four novel biomarkers for coronary heart disease.

As they reported in PLOS Genetics today, researchers led by Uppsala University's Erik Ingelsson studied the metabolomes of more than 3,600 individuals to find four metabolites associated with disease risk: monoglyceride, sphingomyelin, and two types of lysophosphatidylcholine.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jul
11
Sponsored by
Genomenon

This webinar will discuss an approach for automating variant classification using the American College of Medical Genetics and Genomics guidelines.